These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6701664)

  • 1. [Pyrogenal in the combined therapy of erysipelatous inflammation].
    Frolov VM; Shlykova SI
    Sov Med; 1984; (1):95-8. PubMed ID: 6701664
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of pyrogenal in the combined therapy of erysipelas].
    Zhivitsa LV; Zeĭgermakher GA; Knysh EN; Predeina VA
    Vrach Delo; 1986 Oct; (10):24-6. PubMed ID: 3798883
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immune preparations in the overall therapy and prevention of erysipelatous inflammation].
    Khlestkov AA; Raskovalov MG; Ebert LIa
    Voen Med Zh; 1976 Jan; (1):48-9. PubMed ID: 1258419
    [No Abstract]   [Full Text] [Related]  

  • 4. [T-activin in the treatment of patients with recurrent erysipelas and concomitant eczema].
    Frolov VM; Peresadin NA; Gaĭdash IS; Baskakov IN; Tishchenko NA
    Vestn Dermatol Venerol; 1989; (9):47-51. PubMed ID: 2609765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of pyrogenal in the overall treatment of infectious diseases (a review of the literature)].
    Zeĭgermakher GA
    Vrach Delo; 1980 Feb; (2):105-7. PubMed ID: 6989111
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of tserigel in the combined treatment of patients with erysipelatous inflammation].
    Zimnenko PA; Sen'ko VP; Mochalov NI
    Vestn Khir Im I I Grek; 1986 Feb; 136(2):66. PubMed ID: 3705346
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of pyrogenal in the combined treatment of torpid destructive forms of pulmonary tuberculosis].
    Bilyk MA; Dudchik GKh
    Vrach Delo; 1982 Jan; (1):29-31. PubMed ID: 7073854
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinico-immunological evaluation of antibiotic thereapy and prevention of frequent recurrences of erysipelas].
    Cherkasov VL; Iakhontova NK; Chistenkov NA
    Klin Med (Mosk); 1974 Feb; 52(2):52-7. PubMed ID: 4466916
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of corticosteroid hormones and pyrogenal on the humoral factors of natural immunity in pulmonary tuberculosis].
    Mezhebovskiĭ VR
    Probl Tuberk; 1981 Jun; (6):25-8. PubMed ID: 7279903
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effectiveness in treating patients with different clinical forms of erysipelas].
    Kriukova ZV; Kriukova SA; Panichkina LN
    Vrach Delo; 1986 Aug; (8):121-2. PubMed ID: 3776149
    [No Abstract]   [Full Text] [Related]  

  • 11. [Erysipelas in the young population of a military hospital].
    Mahé E; Toussaint P; Lamarque D; Boutchnei S; Guiguen Y
    Ann Dermatol Venereol; 1999; 126(8-9):593-9. PubMed ID: 10530346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of sodium nucleinate on the effectiveness of antibiotic therapy of erysipelas].
    Frolov VM; Rychnev VE; Peresadin NA
    Antibiotiki; 1984 Feb; 29(2):132-5. PubMed ID: 6703667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [INDICATORS OF PHAGOCYTIC ACTIVITY OF MONOCYTES AND CYTOKINE PROFILE IN PATIENTS WITH ERYSIPELAS OF VARYING SEVERITY].
    Belyaeva OA; Shendrik VG; Kuznetsova LV
    Klin Khir; 2016; (7):54-7. PubMed ID: 30256595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intralymphatic antibiotic therapy in erysipelas of the lower limbs].
    Ermolov AS; Cherkasov VL; Udovskiĭ EE; Samotolkin KN; Ryskind RR; Grigorian AR; Mamedov BA
    Sov Med; 1989; (8):95-9. PubMed ID: 2814680
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of pyrogenal on dynamics of reflex-motor disorders in patients with diffuse sclerosis].
    Tiazhkorob AM; Il'iash TI; Zhovnir IK
    Vrach Delo; 1988 Nov; (11):81-3. PubMed ID: 3238989
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prostaglandins in erysipelas].
    Cherkasov VL; Bol'shakova TD; Meshcheriakova SV; Mikerin SM
    Sov Med; 1986; (8):26-8. PubMed ID: 3465043
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chemotherapy effectiveness using tuberculin, prodigiozan and pyrogenal in destructive pulmonary tuberculosis].
    Insanov AV
    Probl Tuberk; 1981 Oct; (10):31-2. PubMed ID: 7312847
    [No Abstract]   [Full Text] [Related]  

  • 18. [The significance of autoimmune reactions in the treatment of erysipelas].
    Frolov VM; Peresadin NA; Baskakov IN; Trofimenko AN; Starik AD
    Vrach Delo; 1988 Sep; (9):107-10. PubMed ID: 3212978
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effectiveness of the use of zaditen and leakadin in recurrent erysipelas].
    Frolov VM; Peresadin NA; Pinskiĭ LL; Korobka IuN; Pustovoĭ IuG
    Ross Med Zh; 1992; (3):38-9. PubMed ID: 1643358
    [No Abstract]   [Full Text] [Related]  

  • 20. [Erysipelatous inflammation].
    Frolov VM; Rychnev VE
    Feldsher Akush; 1984 Feb; 49(2):24-7. PubMed ID: 6562023
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.